Corporate News     13-Feb-23
Biocon Biologics update on USFDA's CRL issued to partner Viatris (Mylan)
Biocon Biologics announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) for Bevacizumab filed by the company's partner Viatris (Mylan). The CRL informs the need for a satisfactory resolution of the observations made during the facility inspection conducted in August, 2022.

"We have submitted a comprehensive Corrective and Preventive Action (CAPA) plan, to the agency and are confident of addressing the observations within the stipulated timeframe. The CRL did not identify any outstanding scientific issues with the dossier", said the company spokesperson.

Previous News
  Biocon to consider fund Raising
 ( Corporate News - 21-Apr-25   09:37 )
  Biocon unit gets U.S. FDA nod for cancer drug biosimilar
 ( Hot Pursuit - 10-Apr-25   11:07 )
  Benchmarks trade with small gains; media shares witness bargain buying
 ( Market Commentary - Mid-Session 25-Feb-25   10:31 )
  Biocon Ltd up for third straight session
 ( Hot Pursuit - 05-Mar-25   13:06 )
  Biocon Ltd soars 2.25%, up for fifth straight session
 ( Hot Pursuit - 11-Jun-24   13:00 )
  Board of Biocon recommends final dividend
 ( Corporate News - 16-May-24   17:54 )
  Biocon to convene board meeting
 ( Corporate News - 02-Apr-25   10:19 )
  Biocon’s board to mull fund raising plans on 4 April
 ( Hot Pursuit - 02-Apr-25   08:09 )
  Biocon appoints Interim CFO
 ( Corporate News - 11-Jun-24   17:16 )
  Biocon gains after subsidiary secures 'Yesafili' entry into Canadian market
 ( Hot Pursuit - 04-Mar-24   11:42 )
  Biocon rises after subsidiary gets approval for multiple ANDAs from US FDA
 ( Hot Pursuit - 05-Mar-25   10:51 )
Other Stories
  Axis Bank allots 1.58 lakh equity shares under ESOP
  30-Apr-25   19:45
  Alivus Life Sciences allots 92,096 equity shares under ESOS
  30-Apr-25   19:38
  Board of Godrej Agrovet allots 32,204 equity shares under ESGS
  30-Apr-25   19:33
  Swastika Investmart to conduct AGM
  30-Apr-25   17:53
  Board of Swastika Investmart recommends final dividend
  30-Apr-25   17:53
  Board of Mukesh Babu Financial Services recommends final dividend
  30-Apr-25   17:48
  Board of Sona BLW Precision Forgings recommends final dividend
  30-Apr-25   17:33
  Board of JSW Infrastructure recommends final dividend
  30-Apr-25   17:33
  Board of Paras Defence & Space Techs. recommends final dividend
  30-Apr-25   17:33
  Board of MAS Financial Services recommends final dividend
  30-Apr-25   17:33
Back Top